Trump's planned heavy tariffs on pharmaceuticals threaten global drug supplies, impacting weight-loss drugs like Ozempic and Mounjaro. Experts warn of disruptions and price hikes, affecting millions of users in the UK and US. Pharmaceutical companies are assessing the situation, while concerns rise over access and affordability. The UK government is urged to monitor the potential impact closely.
